Characterizations of HCV NS5A replication complex inhibitors
- PMID: 23896639
- DOI: 10.1016/j.virol.2013.06.032
Characterizations of HCV NS5A replication complex inhibitors
Abstract
The hepatitis C virus NS5A protein is an established and clinically validated target for antiviral intervention by small molecules. Characterizations are presented of compounds identified as potent inhibitors of HCV replication to provide insight into structural elements that interact with the NS5A protein. UV-activated cross linking and affinity isolation was performed with one series to probe the physical interaction between the inhibitors and the NS5A protein expressed in HCV replicon cells. Resistance mapping with the second series was used to determine the functional impact of specific inhibitor subdomains on the interaction with NS5A. The data provide evidence for a direct high-affinity interaction between these inhibitors and the NS5A protein, with the interaction dependent on inhibitor stereochemistry. The functional data supports a model of inhibition that implicates inhibitor binding by covalently combining distinct pharmacophores across an NS5A dimer interface to achieve maximal inhibition of HCV replication.
Keywords: Antiviral; Covalent attachment; Daclatasvir; HCV; NS5A dimer; NS5A replication complex inhibitor.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.Gastroenterology. 2014 Nov;147(5):1094-105.e25. doi: 10.1053/j.gastro.2014.07.019. Epub 2014 Jul 18. Gastroenterology. 2014. PMID: 25046163
-
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization.J Gen Virol. 2011 Nov;92(Pt 11):2502-2511. doi: 10.1099/vir.0.034801-0. Epub 2011 Jul 27. J Gen Virol. 2011. PMID: 21795470
-
Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.Virology. 2015 Feb;476:168-179. doi: 10.1016/j.virol.2014.12.018. Epub 2014 Dec 26. Virology. 2015. PMID: 25546252 Free PMC article.
-
Antiviral activity and resistance of HCV NS5A replication complex inhibitors.Curr Opin Virol. 2013 Oct;3(5):514-20. doi: 10.1016/j.coviro.2013.06.014. Epub 2013 Jul 27. Curr Opin Virol. 2013. PMID: 23896281 Review.
-
Current perspective of HCV NS5B inhibitors: a review.Curr Med Chem. 2011;18(36):5564-97. doi: 10.2174/092986711798347234. Curr Med Chem. 2011. PMID: 22172066 Review.
Cited by
-
Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication.J Biol Chem. 2019 Aug 30;294(35):13171-13185. doi: 10.1074/jbc.RA119.009537. Epub 2019 Jul 17. J Biol Chem. 2019. PMID: 31315928 Free PMC article.
-
Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure-activity relationship studies.RSC Adv. 2018 Sep 12;8(55):31803-31821. doi: 10.1039/c8ra05471a. eCollection 2018 Sep 5. RSC Adv. 2018. PMID: 35548241 Free PMC article.
-
Synergistic Activity of Combined NS5A Inhibitors.Antimicrob Agents Chemother. 2015 Dec 28;60(3):1573-83. doi: 10.1128/AAC.02639-15. Antimicrob Agents Chemother. 2015. PMID: 26711745 Free PMC article.
-
The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors.Protein Sci. 2014 Jun;23(6):723-34. doi: 10.1002/pro.2456. Epub 2014 Apr 5. Protein Sci. 2014. PMID: 24639329 Free PMC article.
-
Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA.Sci Rep. 2014 Apr 23;4:4765. doi: 10.1038/srep04765. Sci Rep. 2014. PMID: 24755925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources